Sono Tek Corp (SOTK) Stock Analysis and Metrics

Sono Tek

NASDAQ: SOTK

$5.34 ▲ +0.19 (+3.69%)

At close: Jul 8, 2026 · 4:00 PM UTC

Financial Ratios

Market Cap92.43 Mn

P/E51.19

P/S4.42

Div. Yield0.00

ROIC (Qtr)0.00

Revenue Growth (1y) (Qtr)9.54

Add ratio to table…

About

Sono-Tek Corporation is the world leader in the design and manufacture of ultrasonic coating systems that apply precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components. The company’s technology uses high frequency ultrasonic vibrations to atomize liquids into minute droplets that can be deposited at low velocity, creating uniform microscopic layers on substrates such as glass and metal. Its coating solutions are used to prevent blood coagulation in diagnostic tubes, to apply flux on printed circuit boards, to enhance durability and clarity of glass, to deposit drug layers on medical implants and to provide catalytic coatings for alternative energy devices. Sono-Tek serves the microelectronics/electronics, alternative energy, medical, industrial and emerging research and development markets from its headquarters in Milton, New York, supported by a sales and service office in Singapore and an application process development laboratory in Guangzhou, China. The firm has maintained ISO 9001 certification since 1998 and its fiscal year ends on the last day of February, except in leap years when it ends on February 29.

Sono-Tek generates revenue primarily from the sale of custom engineered ultrasonic coating equipment, including multi axis coating systems, integrated coating systems, fluxing systems and OEM systems. The company also earns income from application consulting services, technical training and after sales support provided by its direct sales force, independent distributors and global sales representatives. Products are sold directly to original equipment manufacturers, distributors and end user customers in the industries it serves. In fiscal 2024, 45% of total net sales, equivalent to $8,822,000, came from customers located outside the United States and Canada. The remaining sales are generated within the United States and Canada.

Within the ultrasonic coating equipment industry, Sono-Tek holds a leading position due to its patented nozzle technology and deep applications engineering expertise. The company competes against alternative coating methods and other global and regional manufacturers of nozzles and related products on the basis of price, quality, product features, application engineering and follow up service. In emerging markets where its ultrasonic technology is less known, competition is limited, allowing Sono-Tek to leverage its uniqueness. Competitive advantages include a strong reputation for product quality and reliability, responsive customer service, a debt free balance sheet that provides financial flexibility, and a culture of continuous innovation supported by ongoing research and development. During fiscal 2024, research and development expenses totaled $2,886,000, representing 14.6% of sales, while in fiscal 2023 they were $2,149,000 or 14.3% of sales. Sono-Tek’s business is based in part on technology covered by U. S. patents and unpatented know-how in nozzle design and production, protected by employee nondisclosure and noncompete agreements and reciprocal arrangements with key customers.

The company serves a diverse customer base that includes original equipment manufacturers, distributors and end user customers in the microelectronics, medical, industrial, alternative energy and research sectors. Specific end users range from manufacturers of printed circuit boards to producers of medical devices such as stents, balloons, lenses and diagnostic equipment. Sono-Tek’s technology is used by flat glass manufacturers for windows and automotive applications to improve durability, create filters, increase clarity, reduce reflection, enable conductivity and enhance safety. In the industrial sector, textile producers apply antimicrobial, antistain, flame retardant and moisture barrier coatings, while food packaging firms use antimicrobial layers and food processors add flavors, ingredients and other additives. Alternative energy developers rely on Sono-Tek to coat fuel cells, solar cells and components for green hydrogen systems with catalytic, barrier or facilitator materials. The firm also works with universities, research institutions and government agencies engaged in emerging coating applications at laboratories and pilot facilities.

Investment Thesis

▲ Bull case

SOTK's strategic shift toward high ASP production systems is creating substantial margin expansion potential that the market has not fully priced in, with gross margins reaching 51% and operating income growing 81% year-over-year in FY26 despite only 2% revenue growth, indicating significant operating leverage from higher-value product mix and U.S.-centric sales (67% of revenue) that reduce international cost volatility and support sustainable profitability; this transition is evidenced by the 91% surge in integrated (inline) coating systems and 54% medical sector growth, driven by balloon catheter coating and diagnostic applications, which are less cyclical than clean energy and benefit from entrenched customer relationships where Sono-Tek is evolving from equipment supplier to process expertise provider, allowing for upsell opportunities as seen in quoting discussions where initial $1M systems often expand to $4M-$6M through added capabilities, a dynamic that could accelerate revenue recognition beyond current conservative guidance if lead times compress or order frequency increases from the current lumpiness.
The company's expansion of manufacturing capacity through mezzanine construction and potential adjacent space utilization—targeting a $35M to $45M revenue run rate—represents a tangible, underappreciated catalyst for scalable growth, especially as Sono-Tek operates with no debt and $14.8M in cash, enabling self-funded expansion without dilution; CFO Bagley noted operating cash flow surged to $3.2M from $525K prior year, reflecting strong working capital dynamics and profitability that could fund up to 60% of the estimated $500K-$600K mezzanine investment internally, while NY State economic development support remains a viable non-dilutive supplement, and this capacity expansion directly addresses the constraint highlighted by Ted Jackson regarding lumpy backlog conversion, as increased throughput would allow more consistent shipment of high ASP systems and reduce revenue volatility from order timing.
SOTK's advancement in 300-millimeter wafer coating technology for semiconductor fabs presents a multi-year runway of high-margin opportunity that is being underestimated due to delayed delivery expectations (FY28), with Harshbarger confirming active customer pull rather than vendor push, indicating validated demand for solutions addressing the 200mm to 300mm transition in photoresist applications; this positions Sono-Tek to capture share in a niche where few competitors offer integrated, precision coating capabilities for advanced semiconductor manufacturing, and early engagement at Semicon Europe builds brand credibility that could convert to orders in FY27 with ramp in FY28, complementing medical and microelectronics growth while diversifying away from policy-sensitive clean energy, and given the company's history of conservative guidance, any earlier-than-expected fab system adoption would materially upside FY27/FY28 revenue projections currently modeled as flat to modestly higher.

SOTK's strategic shift toward high ASP production systems is creating substantial margin expansion potential that the market has not fully priced in, with gross margins reaching 51% and operating income growing 81% year-over-year in FY26 despite only 2% revenue growth, indicating significant operating leverage from higher-value product mix and U.S.-centric sales (67% of revenue) that reduce international cost volatility and support sustainable profitability; this transition is evidenced by the 91% surge in integrated (inline) coating systems and 54% medical sector growth, driven by balloon catheter coating and diagnostic applications, which are less cyclical than clean energy and benefit from entrenched customer relationships where Sono-Tek is evolving from equipment supplier to process expertise provider, allowing for upsell opportunities as seen in quoting discussions where initial $1M systems often expand to $4M-$6M through added capabilities, a dynamic that could accelerate revenue recognition beyond current conservative guidance if lead times compress or order frequency increases from the current lumpiness.
The company's expansion of manufacturing capacity through mezzanine construction and potential adjacent space utilization—targeting a $35M to $45M revenue run rate—represents a tangible, underappreciated catalyst for scalable growth, especially as Sono-Tek operates with no debt and $14.8M in cash, enabling self-funded expansion without dilution; CFO Bagley noted operating cash flow surged to $3.2M from $525K prior year, reflecting strong working capital dynamics and profitability that could fund up to 60% of the estimated $500K-$600K mezzanine investment internally, while NY State economic development support remains a viable non-dilutive supplement, and this capacity expansion directly addresses the constraint highlighted by Ted Jackson regarding lumpy backlog conversion, as increased throughput would allow more consistent shipment of high ASP systems and reduce revenue volatility from order timing.
SOTK's advancement in 300-millimeter wafer coating technology for semiconductor fabs presents a multi-year runway of high-margin opportunity that is being underestimated due to delayed delivery expectations (FY28), with Harshbarger confirming active customer pull rather than vendor push, indicating validated demand for solutions addressing the 200mm to 300mm transition in photoresist applications; this positions Sono-Tek to capture share in a niche where few competitors offer integrated, precision coating capabilities for advanced semiconductor manufacturing, and early engagement at Semicon Europe builds brand credibility that could convert to orders in FY27 with ramp in FY28, complementing medical and microelectronics growth while diversifying away from policy-sensitive clean energy, and given the company's history of conservative guidance, any earlier-than-expected fab system adoption would materially upside FY27/FY28 revenue projections currently modeled as flat to modestly higher.

▼ Bear case

SOTK's reliance on lumpily timed high ASP orders creates significant revenue visibility challenges that the market may be underestimating, as acknowledged by Harshbarger when he stated that orders received two months from now would likely push into FY28, making current fiscal year performance highly dependent on securing large system bookings in the next 1-2 months—a narrow window with no guarantee of conversion—and this variability is exacerbated by the shift toward $3M-$5M systems, where a single delayed order can cause quarterly revenue swings of 20%+; despite a solid $9.12M backlog, the book-to-bill ratio of roughly 0.4 and bookings around $2.5M (as noted by Ted Jackson) indicate weak order inflow relative to revenue needs, suggesting the backlog is being consumed faster than replenished, and without consistent monthly high ASP order flow, the company risks periods of underutilized capacity even as it invests in expansion, undermining the operating leverage thesis.
The clean energy market decline, particularly in electrolysis-related demand which fell 19% in FY26, may represent a more structural headwind than management admits, given policy shifts at the government level that Harshbarger attributed to the downturn, and while solar-related shipments provided partial offset earlier in the year, the lack of discussion on policy durability or diversification progress beyond medical/microelectronics raises concern that Sono-Tek's clean energy exposure remains tied to volatile subsidy-dependent sectors; with U.S. and Canada representing 67% of revenue and growing 12%, the company's domestic focus could amplify sensitivity to federal policy changes, and if clean energy does not recover or transition effectively to other markets, the industrial basket decline and multi-axis system contraction could persist, limiting upside from diversification efforts and forcing renewed reliance on lower-margin, lower-volume fluxing systems that grew 53% on Asia demand but face geographic softness.
SOTK's elevated R&D and SG&A investment trajectory, while framed as strategic, may not be yielding proportional returns, as G&A expenses rose 14% to $2.66M driven by higher salaries, insurance, and stock-based compensation, outpacing the 2% revenue growth and suggesting potential inefficiency in scaling administrative functions, and although R&D decreased 6% to $2.55M, this reduction coincides with claims of heavy investment in 300mm wafer and integrated system development, raising questions about whether innovation spending is being sufficiently prioritized or if cost cuts are masking underfunding in critical growth areas; meanwhile, the minimal use of the stock buyback program despite $14.8M in cash signals management's preference for reinvestment, but without clear ROI metrics on expansion projects like the mezzanine or adjacent space lease, there is risk that capital allocation favors empire-building over shareholder value, especially if the targeted $35M-$45M revenue run rate requires disproportionate headcount growth—Bagley estimated only 30%-40% increase for a doubling of revenue, implying operating leverage, but historical hiring patterns in manufacturing and field engineering could exceed this if new systems demand more specialized labor, eroding margin gains.

SOTK's reliance on lumpily timed high ASP orders creates significant revenue visibility challenges that the market may be underestimating, as acknowledged by Harshbarger when he stated that orders received two months from now would likely push into FY28, making current fiscal year performance highly dependent on securing large system bookings in the next 1-2 months—a narrow window with no guarantee of conversion—and this variability is exacerbated by the shift toward $3M-$5M systems, where a single delayed order can cause quarterly revenue swings of 20%+; despite a solid $9.12M backlog, the book-to-bill ratio of roughly 0.4 and bookings around $2.5M (as noted by Ted Jackson) indicate weak order inflow relative to revenue needs, suggesting the backlog is being consumed faster than replenished, and without consistent monthly high ASP order flow, the company risks periods of underutilized capacity even as it invests in expansion, undermining the operating leverage thesis.
The clean energy market decline, particularly in electrolysis-related demand which fell 19% in FY26, may represent a more structural headwind than management admits, given policy shifts at the government level that Harshbarger attributed to the downturn, and while solar-related shipments provided partial offset earlier in the year, the lack of discussion on policy durability or diversification progress beyond medical/microelectronics raises concern that Sono-Tek's clean energy exposure remains tied to volatile subsidy-dependent sectors; with U.S. and Canada representing 67% of revenue and growing 12%, the company's domestic focus could amplify sensitivity to federal policy changes, and if clean energy does not recover or transition effectively to other markets, the industrial basket decline and multi-axis system contraction could persist, limiting upside from diversification efforts and forcing renewed reliance on lower-margin, lower-volume fluxing systems that grew 53% on Asia demand but face geographic softness.
SOTK's elevated R&D and SG&A investment trajectory, while framed as strategic, may not be yielding proportional returns, as G&A expenses rose 14% to $2.66M driven by higher salaries, insurance, and stock-based compensation, outpacing the 2% revenue growth and suggesting potential inefficiency in scaling administrative functions, and although R&D decreased 6% to $2.55M, this reduction coincides with claims of heavy investment in 300mm wafer and integrated system development, raising questions about whether innovation spending is being sufficiently prioritized or if cost cuts are masking underfunding in critical growth areas; meanwhile, the minimal use of the stock buyback program despite $14.8M in cash signals management's preference for reinvestment, but without clear ROI metrics on expansion projects like the mezzanine or adjacent space lease, there is risk that capital allocation favors empire-building over shareholder value, especially if the targeted $35M-$45M revenue run rate requires disproportionate headcount growth—Bagley estimated only 30%-40% increase for a doubling of revenue, implying operating leverage, but historical hiring patterns in manufacturing and field engineering could exceed this if new systems demand more specialized labor, eroding margin gains.

Segments Breakdown of Revenue (2026)

Peer Comparison

Companies in the Scientific & Technical Instruments

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	COHR	Coherent Corp.	3,591.32 Bn	8,242.43	543.97	3.19 Bn
2	NOVT	Novanta Inc	69.39 Bn	1,291.61	69.04	0.24 Bn
3	KEYS	Keysight Technologies, Inc.	57.75 Bn	58.86	10.17	2.53 Bn
4	TDY	Teledyne Technologies Inc	30.63 Bn	32.80	4.92	2.48 Bn
5	FTV	Fortive Corp	19.14 Bn	-1,495.03	4.52	3.49 Bn
6	TRMB	Trimble Inc.	12.33 Bn	27.03	3.34	1.41 Bn
7	CGNX	Cognex Corp	11.87 Bn	83.30	11.34	-
8	ST	Sensata Technologies Holding plc	6.78 Bn	139.80	1.82	2.83 Bn

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2026)

Segments Breakdown of Revenue (2026)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2026)

Segments Breakdown of Revenue (2026)

Peer Comparison

Create an account

Sign In

Reset Password